IQVIA Holdings Inc. (NYSE: IQV)
Health Care · Life Sciences Tools & Services · US
$259.42
-0.32% today · +38.0% 1Y
IQVIA Holdings Inc. (NYSE: IQV) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $42.70B and employs 94,000 people.
Over the last twelve months the share price has gained 38.0%, trading between 154.50 and 261.88.
Tweenvest scores IQVIA Holdings Inc. across four factors: quality 66/100, value 53/100, growth 53/100. Its strongest factor is quality.
IQV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.70B
- Revenue (TTM)
- $16.98B
- P/E
- 32.12
- EPS
- 8.08
- Dividend yield
- —
- Beta (5Y)
- 1.17
- 52-week high
- $261.88
- 52-week low
- $154.50
- Avg volume (3M)
- —
- Shares outstanding
- 164.60M
- Employees
- 94,000
- Next earnings
- —
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- ISIN
- US46266C1053
- Listed since
- May 9, 2013
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.97 | +0.40% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF593.80 | +1.02% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $154.77 | +0.87% |
| Waters CorporationNYSE: WAT | $40.72B | $414.44 | +0.90% |
| Illumina, Inc.NasdaqGS: ILMN | $33.97B | $224.99 | +0.79% |
Figures last refreshed Aug 18, 2026.